Abstract
A recent goal of synthetic biology has been to identify new chassis that provide benefits lacking in model organisms. Vibrio natriegens is a marine Gram-negative bacterium which is an emergent synthetic biology chassis with inherent benefits: An extremely fast growth rate, genetic tractability, and the ability to grow on a variety of carbon sources (“feedstock flexibility”). Given these inherent benefits, we sought to determine its potential to heterologously produce natural products, and chose beta-carotene and violacein as test cases. For beta-carotene production, we expressed the beta-carotene biosynthetic pathway from the sister marine bacterium Vibrio campbellii, as well as the mevalonate biosynthetic pathway from the Gram-positive bacterium Lactobacillus acidophilus to improve precursor abundance. Violacein was produced by expressing a biosynthetic gene cluster derived from Chromobacterium violaceum. Not only was V. natriegens able to heterologously produce these compounds in rich media, illustrating its promise as a new chassis for small molecule drug production, but it also did so in minimal media using a variety of feedstocks. The ability for V. natriegens to produce natural products with multiple industrially-relevant feedstocks argues for continued investigations into the production of more complex natural products in this chassis.
Keywords: Vibrio, beta-carotene, violacein, marine bacteria
1. Introduction
In order to expand the capabilities of engineered organisms, synthetic biologists have begun exploring non-model organisms that display characteristics not found in model organisms such as Escherichia coli [1,2,3]. The type strain of Vibrio natriegens is a Gram-negative, facultatively anaerobic, salt marsh isolate [4], that has been put forward as an emergent synthetic biology chassis due in large part to its non-pathogenic nature and extremely fast growth rate (reported doubling time < 10 min) [5,6,7,8,9,10,11,12]. To put this in context, its growth rate using glucose is at least two times faster than some industrially-relevant microorganisms including E. coli, Bacillus subtilis, Corynebacterium glutamicum, and yeast [7]. V. natriegens has a growth rate in glucose minimal medium (1.7 h−1) that is higher than even E. coli that has undergone adaptive laboratory evolution (~1.0 h−1), and 1.0 h−1 appears to be the upper limit for E. coli growth rate [9].
Many natural characteristics of V. natriegens support the investigation of this emergent chassis for bioproduction use in particular. First, V. natriegens has been characterized phenotypically and genomically, and is believed to be a generally safe biological agent (i.e., BSL-1) [5,7,8,9,10,11,12]. Second, as V. natriegens has garnered interest as an emergent chassis, genetic tools have been developed [8,10,12]. In concert with this, its extremely fast growth rate assists in genetically engineering this organism [7,12,13]. Third, its tolerance to high salt—in some media, up to 30 g·L−1 (~0.51 M) with an optimum at 15 g·L−1 (~0.26 M)—coupled to fast growth could help maintain axenic fermentation conditions without expensive antibiotic techniques; high salt tolerance has been referenced as an advantage for other emergent chassis such as Halomonas which grows in 60 g·L−1 NaCl [7,14,15]. Illustrating the flexibility of V. natriegens, if non-corrosive fermenters are not available to accommodate high-salt growth, it can still be grown with a low chlorine-based media [7,14,15]. Fourth, to support its rapid growth, V. natriegens must intrinsically be able to consume carbon sources very efficiently. Indeed, in regards to glucose, it has been found to have a remarkably high biomass specific substrate consumption rate (qs) of greater than double that of E. coli, Pseudomonas putida, yeast, and C. glutamicum (20X for C. glutamicum) and an uptake rate of 3.90 g g−1·h−1 (21.4 mmol gDW−1 h−1) [7,9]. This portends the ability for V. natriegens to likewise efficiently convert carbon sources to bioproducts [7]. Finally, and of particular importance in this study, is that V. natriegens is special in that it can grow efficiently on a variety of industrially-relevant feedstocks [7]. In fact, vibrios dedicate approximately half of their open reading frames to metabolism (carbohydrates, RNA, and proteins) [8]. Feedstock flexibility is incredibly important for consideration of an emergent chassis for bioproduction, as at large scales, the feasibility of a given bioprocess can be influenced by the cost, availability, and competing uses of the carbon source [16]. In fact, a major cost factor for microbial bioproduction of bulk chemicals is the carbon source [17,18]. The ability of chassis to grow and produce on a variety of feedstocks allows for adjusting to market changes in feedstock prices. Further, since most hydrolysates are a mixture of carbon sources, co-utilization of these breakdown products is extremely desirable; unfortunately, this natural ability is rare in microbial production chassis [16].
Inspired by these inherent V. natriegens characteristics, we sought to investigate its ability to heterologously produce natural products as example bioproduction targets and chose the carotenoid beta-carotene and the bis-indole violacein as target cases. Both of these natural products have previously been heterologously-expressed in microbial chassis [19,20,21,22,23,24,25,26,27,28,29]; our goal here was not to compete with these other chassis (e.g., for production yield), but to demonstrate the ability of V. natriegens, which has desirable intrinsic characteristics and potential feedstock flexibility, as an alternative chassis for natural product production.
2. Results
2.1. Investigating V. natriegens Feedstock Flexibility
To investigate the ability of V. natriegens to grow on diverse substrates, V. natriegens ATCC 14048 was subjected to Phenotype MicroArray™ testing using OmniLog® V. 1.5 Comparison (BioLog, Hayward, CA; see Materials and Methods for more information). Cells were grown in proprietary minimal media in a microplate with individual wells supplemented by different carbohydrate sources, and cell respiration was determined kinetically by measuring NADH production through reduction of a tetrazolium dye over time. The average response height for each well throughout the assay was normalized to a reference cell without substrate, and those carbohydrates allowing cellular respiration over a threshold level of 50 are depicted in Table 1 (See Appendix A, Table A1, for additional information on screened carbon sources). While these results indicate respiration and substrates that may be more metabolically favorable, this does not necessarily correlate to growth rate. However, these results do corroborate and extend upon the findings by Hoffart et al. and Tschirhart et al. who examined V. natriegens growth rates with a variety of carbon sources [7,10]. In fact, all carbohydrates shown by Hoffart et al. and Tschirhart et al. to allow V. natriegens growth were found above the response threshold in our screen as well (Hoffart et al. also demonstrated V. natriegens grew with starch, which was not tested in our screen) [7,10].
Table 1.
Carbohydrates | ||
---|---|---|
N-Acetyl-D-glucosamine 1 | D-Galactose | Maltotriose |
Adenosine | Gentiobiose | D-Mannitol 1 |
D-Arabinose | Glycerol 1 | ß-Methyl-D-glucoside |
L-Arabinose1 | D,L-α-Glycerol phosphate | L-Rhamnose |
D-Arabitol | D-Glucosamine | D-Ribose |
Arbutin | α-D-Glucose 1 | Sucrose1 |
D-Cellubiose | Inosine | Thymidine |
2′-Deoxyadenosine | L-Lyxose | D-Trehalose |
D-Fructose1 | Maltose | Uridine |
1 Denotes those selected for testing herein.
Based upon these findings and their potential as feedstocks, we chose seven carbon sources to investigate (glucose, fructose, arabinose, glycerol, mannitol, N-acetyl-glucosamine, or sucrose at 4 g·L−1, 0.4%) in minimal medium along with LBv2 rich medium for production of natural products (Table 1). In terms of growth as determined by Hoffart et al., the carbon sources can be broken into two groups: Sucrose, N-acetyl glucosamine, glucose, and fructose promote fast growth (>1.5 h−1); while glycerol and arabinose promote slower growth (<1 h−1) (mannitol was not tested by Hoffart et al., but in Tschirhart et al. had a doubling time closer to the carbon sources promoting fast growth) [7,10].
2.2. Heterologous Production of Beta-carotene in V. natriegens
2.2.1. Construction and Expression of The V. Campbellii Beta-Carotene Biosynthesis Pathway and L. acidophilus Mevalonate Pathway
While V. natriegens does not naturally encode the four key biosynthetic genes necessary for beta-carotene production, it does contain one upstream pathway to produce the two key building blocks for isoprenoids: Isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). This pathway is termed the 2-C-methyl-d-erythritol-4-phosphate (MEP) pathway, and branches from glycolysis, starting with glyceraldehyde-3-phosphate and pyruvate, as seen in Figure 1A [8,11,30,31]. We chose four genes for beta-carotene synthesis that utilize these building blocks from the sister species V. campbellii BAA-1116 (Figure 1A; see Appendix B, Table A2 for gene IDs and enzyme names) [32,33]. This cluster was placed under the control of an isopropyl-ß-D-thiogalactoside (IPTG)-inducible Ptac promoter (plasmid pJV-ß-carotene) (Figure 1A,B; for plasmid map, see Appendix C, Figure A1A) [34,35].
Extending beyond heterologously-expressing intragenus genes, and to potentially improve the production of the IPP and DMAPP precursors, we also expressed the mevalonate pathway from Lactobacillus acidophilus NCFM [36]. This pathway has been used similarly before in other bacteria to increase the yield of beta-carotene [24,26,27,28,29]. The mevalonate pathway branches from pyruvate at the end of glycolysis as seen in Figure 1A. Together, six enzymes convert two acetyl-CoA molecules to IPP. IPP can then be isomerized to DMAPP by the action of the seventh enzyme isopentenyl pyrophosphate isomerase (which can also help balance IPP/DMAPP from the first pathway to meet beta-carotene production needs). The genes were cloned with constitutive expression into the same plasmid as the beta-carotene genes from V. campbellii (plasmid pJV-ß-carotene-MVA) (Figure 1B; for plasmid map, see Appendix C, Figure A1B). This brought the total to 11 genes (in a ~16 kb plasmid) that were heterologously-expressed in this emergent chassis.
2.2.2. Heterologous Production of Beta-Carotene in Nutrient Rich Medium
We first tested production of beta-carotene in LBv2 rich medium before exploring the different carbon sources in minimal media. Using only the four beta-carotene biosynthetic genes and the endogenous MEP pathway (pJV-ß-carotene), V. natriegens was able to produce 0.50 ± 0.02 mg·L−1 of beta-carotene as determined by HPLC-UV. This production increased significantly (p < 0.001) almost 6-fold to 2.93 ± 0.08 mg·L−1 when the additional mevalonate pathway was also expressed (plasmid pJV-ß-carotene-MVA) as shown in Figure 2.
2.2.3. Feedstock Flexibility of V. natriegens for Producing Beta-carotene
We next sought to investigate the feedstock flexibility of V. natriegens for beta-carotene production. V. natriegens harboring the pJV-ß-carotene-MVA plasmid was grown overnight in minimal media supplemented with additional NaCl, MOPS, and 4 g·L−1 (0.4%) of each carbon source. Final relative growth of the transformed V. natriegens in the different carbon sources followed the trends seen in Hoffart et al. and Tschirhart et al., with sucrose, glucose, fructose, mannitol, and N-acetyl-glucosamine promoting greater growth and glycerol promoting lesser growth (Figure 3A). One noticeable difference was arabinose, which also promoted high growth here; however, herein (1) we measured end-point growth and not growth rate, and (2) the expression of the beta-carotene pathway and resistance cassette could have affected growth.
The relative production of beta-carotene on each carbon source largely followed the growth patterns (Figure 3A,B). In terms of overall production, nearly all carbon sources produced similar amounts of beta-carotene. Glycerol was the exception, producing significantly less than glucose, fructose, arabinose, N-acetyl glucosamine, or sucrose (α = 0.05) and this was perhaps due in some cases to significantly lower V. natriegens growth in glycerol versus glucose, arabinose, and sucrose (α = 0.05). On a production per growth (OD600nm) basis, all carbon sources performed similarly (with the exception of growth in fructose producing significantly more than glycerol or mannitol, α = 0.05). This bodes well for the use of V. natriegens as a bioproduction chassis with feedstock flexibility (see Discussion).
2.3. Heterologous Production of Violacein in V. natriegens
2.3.1. Construction of the C. violaceum Violacein Biosynthesis Pathway in V. natriegens
To expand upon our investigation of heterologous natural product production in V. natriegens, we chose to explore the production of violacein. V. natriegens also does not naturally encode for production of violacein but does encode for the precursor tryptophan [8,11,37]. Five enzymes are responsible for transforming tryptophan to violacein; the violacein pathway also contains numerous opportunities for non-enzymatic conversion of intermediates to terminal co-products, which can limit overall yield, as seen in Figure 4A (see Appendix B, Table A2 for gene IDs and enzyme names) [22,37,38,39,40,41]. For violacein production, a plasmid (pVio) containing the violacein biosynthetic pathway (vioABEDC from Chromobacterium violaceum ATCC 12472) was used (Figure 4B; for plasmid map see Appendix C, Figure A2).
2.3.2. Heterologous Production and Feedstock Flexibility of Violacein Production
We tested V. natriegens containing the pVio plasmid in both LBv2 rich medium as well as the minimal media containing different carbon sources described above for production of deoxyviolacein (byproduct) and violacein. V. natriegens was able to produce 24.9 ± 3.1 mg·L−1 of deoxyviolacein and 13.1 ± 0.9 mg·L−1 of violacein in rich medium as determined by HPLC-UV (Figure 5).
Interestingly, the carbon sources that yielded the greatest production of beta-carotene did not yield the greatest production of violacein (Figure 5B,C). In particular, growth in mannitol produced more violacein than glucose, fructose, or N-acetyl-glucosamine (more than glucose or N-acetyl-glucosamine on a per OD600nm basis). In fact, the minimal medium + mannitol (15.5 mg·L−1) and LBv2 rich medium both produced a similar amount of violacein. While the use of mannitol also resulted in higher production of beta-carotene as well, it was not substantially higher than the production observed from use of the other carbon sources. Growth in glycerol also appeared to produce high levels of violacein while its use resulted in a low level of beta-carotene production. Also interesting was the ratio of deoxyviolacein production versus violacein production: In rich medium, more deoxyviolacein was produced relative to violacein (~1.9X), whereas in minimal medium supplemented with the different carbon sources, more violacein was produced relative to deoxyviolacein (~4.2X, on average). Another notable observation was that violacein production by minimal medium + arabinose was excluded since the results would likely be confounded by the arabinose-induced production of the phagemid elements in the plasmid that is used (pVio) [43,44]. In fact, growth of the pVio-containing transformant in minimal medium + arabinose was lower than with the other carbon sources, potentially indicating cellular stress due to the production of these proteins or, less likely, an activation of prophages that resulted in the lysis of V. natriegens [45].
3. Discussion
V. natriegens intrinsically has many desirable characteristics for a bioproduction chassis: Fast growth rate, genetic tractability, biological safety, and growth on a wide variety of carbon sources [4,5,6,7,8,9,10,11,12,13,46]. In regards to growth rate in particular, it has been shown that expression of some heterologous genes can decrease expression of others, due to competition for finite resources in the cell such as RNA polymerase and ribosomes [47,48]. One could expect that fast growth would require more demand on these finite resources, which would then be less available for heterologous expression and a liability for bioproduction. However, it has been shown that increasing growth rate in V. natriegens increases ribosome number up to an estimated 115,000 ribosomes per cell, higher than the estimated 70,000 in E. coli (estimated ~90,000 if E. coli could grow as fast as V. natriegens). The greater number of ribosomes per cell may therefore mitigate some of this liability [46,49]. We also anticipate that V. natriegens will be able to utilize carbon sources very efficiently (vide supra). In this study, we took advantage of the ability of V. natriegens to utilize a variety of feedstocks and examined the production of two natural products by V. natriegens using a complex nutrient rich medium and minimal media supplemented with one of seven carbon sources: glucose, fructose, arabinose, glycerol, mannitol, and N-acetyl-glucosamine, and sucrose.
The carbon sources were chosen based on their natural metabolism by V. natriegens and their potential or current use for industrial bioproduction. Most bioproduction is based on glucose from molasses or from starch hydrolysis [16,18]. Fructose can be derived from sucrose hydrolysis or from wood, but typically costs more than glucose [50,51,52]. Arabinose is found in hemicellulose; E. coli can use this sugar but is limited by glucose repression, whereas natural S. cerevisiae strains cannot use this sugar [16]. Glycerol is easily available as it is a stoichiometric by-product of biodiesel production [16]. Mannitol is one of the most abundant sugars in brown macroalgae (also abundant are carbohydrate polymers alginate and glucan) [53]. Brown macroalgae as a feedstock source is advantageous as it requires no arable land, fresh water, or fertilizer; it is produced in many countries; it is easier to refine due to a lack of lignin; and other products (e.g., proteins) can be used from it as well [53]. N-acetyl glucosamine constitutes chitin; chitin is one of the most abundant polymers in nature, can be retrieved as waste from the shrimp industry, and is considered an under-utilized feedstock [16]. Finally, sucrose from sugarcane and sugar beet is a particularly desirable feedstock, as it is economical and environmentally friendly [54,55]. In fact, it is predicted to become the cheapest feedstock [55,56], in part because cane juice or molasses can be directly fermented (or, if need be, sucrose can be easily purified). In contrast, to utilize glucose, starch must be milled and hydrolyzed [18,57,58]. Further, after sucrose extraction, the remaining sugarcane biomass (bagasse) can be burned for fermentation processes; however, glucose-based processes require fossil fuel burning [18,59]. Importantly, many industrial E. coli strains cannot naturally use sucrose without engineering, whereas V. natriegens can [5,7,8,54,56,57].
3.1. Heterologous Production of Beta-carotene
Carotenoids such as beta-carotene have multiple uses industrially, including for health and as a pigment [60,61]. In addition to beta-carotene as a target chemical, partially overlapping isoprenoid pathways produce other valuable chemicals such as isoprene, arteminisin, limonene, and paclitaxel (Taxol); demonstration of beta-carotene production helps open the door to these compounds as well [27,62,63,64,65,66,67]. Sans optimization, which was beyond the scope of this effort, we noted that the production of beta-carotene in V. natriegens grown in rich medium (0.5 mg·L−1) is on par with production in E. coli (~ 1 mg·L−1) [26,60]. The inclusion of the MVA synthetic pathway, while improving production by ~6-fold, did not improve it to the levels seen in E. coli [26]. We anticipate that enhanced production may be possible by balancing the MVA pathway to preclude buildup of intermediates [68] or through other methods as discussed below. In terms of feedstock flexibility in minimal media, V. natriegens was found to produce beta-carotene in all seven carbon sources tested. We demonstrated that production of beta-carotene roughly followed the relative growth on each carbon source. This may be expected, as the substrates for beta-carotene production (IPP and DMAPP) are biosynthesized from central metabolism glycolysis intermediates/products which would also support growth. Of particular interest was that beta-carotene was produced relatively well in sucrose, portending the use of this desirable feedstock for production of natural products in this chassis.
3.2. Heterologous Production of Violacein
In addition to beta-carotene, we also chose to target violacein, a bacterially-produced bis-indole with reported antibacterial, antitumoral, antiviral, trypanocidal, antiprotozoan, and antioxidant activities [19,20]. While the bacteria Chromobacterium violaceum, Duganella sp., and Janthinobacterium lividum naturally produce violacein, some of the titers (0.85–1.62 g·L−1), their propensity for forming non-violacein-producing variants in culture, and for C. violaceum and J. lividum their potential pathogenicity, limit their use for the industrial production of violacein [20]. Our efforts demonstrated that V. natriegens heterologously produced violacein (and deoxyviolacein) in both rich media and in minimal media containing the six carbon sources tested. In rich medium, the production of violacein with V. natriegens (~13 mg·L−1) was similar to the production observed in E. coli (~15 mg·L−1) when using a plasmid containing the same RBS as pVio [21], although higher production has been demonstrated in other optimized systems [23,25,69,70]. Interestingly, production was high when grown in mannitol or glycerol. High production of violacein with glycerol has also been noted before, though the reasons are unclear [70]. We speculate that the higher degree of reductance for glycerol (4.67) and mannitol (4.33) than for the other carbon sources (4) may increase the concentrations of NAD(P)H in the cell, a needed co-factor for VioD and VioC (we note, however, that we did not notice a significant increase in beta-carotene production for growth in these carbon sources although NADH is needed for its production as well) [60,71,72]. The high production in mannitol portends the ability to produce violacein from brown macroalgae, especially if V. natriegens can be engineered to utilize alginate; its ability to naturally use mannitol lessens the burden of engineering that aspect as well. Another interesting finding was that more deoxyviolacein was produced in rich media relative to violacein, whereas more violacein was produced in the supplemental minimal media relative to deoxyviolacein. This could be due to inhibition or relatively lesser production of VioD in rich media.
In conclusion, we demonstrate for the first time that V. natriegens is capable of substantial heterologous production of the natural products beta-carotene and violacein using a variety of carbon sources and that this production required the use of some of the largest plasmids (up to 16.5 kb) that have been successfully inserted and maintained in this bacterium. The heterologous multi-gene pathways introduced here were between 4.5–12 kb and consisted of up to 11 genes. These pathways, cloned from three different bacteria, did not need to be codon optimized for expression in V. natriegens. Overall, this first demonstration of heterologous natural product production using these different carbon sources serves to further develop the biotechnological usefulness of this organism, which has also been investigated for production of alanine, poly-ß-hydroxybutyrate, and selenium nanoparticles, all using native genes [5,7,73]. We anticipate that these results will encourage future efforts at optimizing bioproduction of other complex natural products in this chassis.
4. Materials and Methods
4.1. Materials and Nomenclature
For all isolations of DNA using polymerase chain reaction (PCR) amplification, and for all PCR amplifications prior to Gibson assembly, Q5 High-Fidelity Polymerase or Q5 Hot Start High-Fidelity Polymerase was used (New England Biolabs, Ipswich, MA, USA) to minimize mutations. Colony PCR was done using NEB’s Taq polymerase (New England Biolabs, Ipswich, MA, USA). For all DNA preparations, either the Monarch® Plasmid Miniprep Kit (New England Biolabs, Ipswich, MA, USA) or the QIAprep® Spin Miniprep kit was used (Qiagen, Venlo, Netherlands). DNA cleaning and/or concentrating was done using the DNA Clean and Concentrator®-5 kit (Zymo Research, Tustin, CA, USA) as needed between PCR/amplification steps, unless otherwise specified. Gibson assembly was done using the Gibson Assembly® Cloning Kit (New England Biolabs, Ipswich, MA, USA) with conditions found with NEBuilder (https://nebuilder.neb.com/, New England Biolabs, Ipswich, MA, USA). All sequencing was performed through Eurofins Genomics (Eurofins Genomics, Luxembourg, Luxembourg). Restriction digestion enzymes came from New England Biolabs (New England Biolabs, Ipswich, MA, USA). All chemicals, including carbon sources, were from Sigma-Aldrich (Sigma-Aldrich, St. Louis, MO, USA), Fisher Scientific (Thermo Fisher Scientific, Waltham, MA, USA), EMD (MilliporeSigma, Burlington, MA, USA), or Cayman Chemicals (Cayman Chemical Company, Ann Arbor, MI, USA). LBv2 medium was made up of 1x LB medium (Miller) with v2 salts. V2 salts consist of: 204 mM NaCl, 4.2 mM KCl, and 23.14 mM MgCl2 [12]. For the minimal medium base we used a variation of M9 minimal salts medium with added NaCl (48 mM Na2HPO4, 22 mM KH2PO4, 18.7 mM NH4Cl, 209 mM NaCl, 0.1 mM CaCl2, 2 mM MgSO4, 100 mM MOPS, 0.4% carbon source per L). Gene names used are either as specified on the National Center for Biotechnology Information website (NBCI; ncbi.nlm.nih.gov) or common homologous names [74,75,76,77]. V. natriegens ATCC 14048 was the strain type used in all final transformations and production studies. Pathways were investigated with help of KEGG (Kanehisa laboratories https://www.kegg.jp). Genome information used was from Bethesda (MD): National Library of Medicine (US), NCBI, and for V. natriegens was from accession numbers NZ_CP009977.1 and NZ_CP016345.1, for V. campbellii from accession numbers NC_009783.1 and NC_022269.1, for L. acidophilus from accession number NC_006814.3, and for C. violaceum from accession number NC_005085.1 [74,75,76,77,78]. For a list of plasmids used in this study, see Table 2.
Table 2.
# | Name | Features | Refs. |
---|---|---|---|
1 | pJV298 | oriT, p15A ori, lacIq, gfp under lacIq control, CmR | [35] |
2 | pA5D5GFP | J23102 promoter, B0032 RBS, gfp, and B0015 terminator assembled in the DVK_AE vector from the CIDAR MoClo kit | [10,82] |
3 | TOPO-ß-carotene | ß-carotene in pCR™4Blunt-TOPO® | This study |
4 | pJV-ß-carotene | pJV298 with crtY, crtB, crtI, crtE under lacIq control | This study |
5 | TOPO-MVA1 | MVA1 cluster in pCR™4Blunt-TOPO® | This study |
6 | TOPO-MVA2 | MVA2 cluster in pCR™4Blunt-TOPO® | This study |
7 | pJV-ß-carotene-A5D5-MVA2 | pJV-ß-carotene; J23102 promoter, B0032 RBS, mvaK, mvaD, pmvk, idi | This study |
8 | pJV-ß-carotene-MVA | pJV-ß-carotene; J23102 promoter, B0032 RBS, thil, hmdH, hmcS, MVA2 | This study |
9 | Bba_J72214-BBa_J72090 | P15A ori, CmR, araBAD promoter, araC, vioA, vioB, vioC, vioE | [43,83] |
10 | Synthesized vioD 1 | Recoded; from C. violaceum ATCC 12472 | This study |
11 | pVio | Bba_J72214-BBa_J72090 with vioD | This study |
1 Synthesized by ATUM (https://www.atum.bio/).
4.2. BioLog Phenotype MicroArrays™
V. natriegens ATCC 14048 was submitted to BioLog (Hayward, CA, USA) for Phenotype MicroArrays (PMs) for Microbial CellsTM analyses on the OmniLog system®. Cells were grown on Biolog Universal Growth media with sheep’s blood at 30 °C overnight. They were then added into the wells of the plates, which were run according to a proprietary protocol for running Gram-negative bacteria. The base test media for the metabolic test plates is proprietary, but it is a minimal media composed mostly of salt and buffers. For more information, see the BioLog website (https://www.biolog.com/products-portfolio-overview/phenotype-microarrays-for-microbial-cells/) and reference papers [79,80].
4.3. Cloning of the Beta-Carotene Pathway
The four gene beta-carotene biosynthetic cluster (see Appendix B, Table A2) was PCR amplified from V. campbellii ATCC BAA-1116 genomic DNA using primers 1 and 2 (Table 3), digested with Dpn1, and underwent A-tailing. A-tailing was accomplished using Taq polymerase and following a protocol from New England Biolabs, but substituting in standard Taq buffer and a dNTP mix (New England Biolabs, Ipswich, MA). The A-tailed construct was inserted into a pCR™4-TOPO® TA vector using the TOPO™ TA Cloning Kit™ for Sequencing (Thermo Fisher Scientific, Waltham, MA, USA) and the reaction transformed into Top10 E. coli. DNA preparation afforded the plasmid TOPO-ß-carotene.
Table 3.
# | Name | Sequence |
---|---|---|
1 | CrtY_F | TCATCTCATCATTCCGATAGCGGCACT |
2 | CrtE_R | ATGAACAGTTCTTCTCGAAGTAAAGCCAG |
3 | pJV-ß-car-R | ATGTATATCTCCTTAAGCTTACGCC |
4 | pJV-ß-car-F | TGAGGATCCGGTGATTGATTG |
5 | Bcar-4pJV-F | gcttaaggagatatacatATGAACAGTTCTTCTCGAAG |
6 | Bcar-4pJV-R | aatcaccggatcctcaTCATCTCATCATTCCGATAG |
7 | Cluster 1 F | ATGAAAGATATTTATATTGTCGCTGC |
8 | Cluster 1 R | TTATTTAACTTTGTATTGACGAACATGGC |
9 | Cluster 2 F | ATGAAAAGTAGTTTTTTAGCTCATGG |
10 | Cluster 2 R | TTATTTAATTAACTGATCAATTTGATTTTTTAGTGGC |
11 | Clust1_ck-F | CGTTGTCGGTGGTTCGATTA |
12 | Clust1-ck-R | ACGAGCAACCCAACCTTATC |
13 | Clust2-ck-F | CTTAGGCGAACTGGCAGATATTA |
14 | Clust2-ck-R | TGAGGTTGGCACGTGATTAG |
15 | A5D5-F | tgccgctatcggaatgatgagatgaggagTTGACAGCTAGCTCAGTC |
16 | A5D5-R | gcagcgacaatataaatatctttcatcattTAGTACTTTCCTGTGTGACTC |
17 | Cluster2-SacI-R | actacttttcatgagctcTTATTTAACTTTGTATTGACGAACATG |
18 | Cluster2-SacI-F | caaagttaaataagagctcATGAAAAGTAGTTTTTTAGCTC |
19 | MVA2-ovrlp-R | caatcaatcaccggatcctcaTTATTTAATTAACTGATCAATTTGATTTTTTAG |
20 | pJV-bcar-n-R | TCATCTCATCATTCCGATAGCG |
21 | pJV-b-m2-4m1-F | CATGTTCGTCAATACAAAGTTAAATAAGAGC |
22 | pJV-b-m2-4m1-R | GCAGCGACAATATAAATATCTTTCATCAT |
23 | pJV-empty-F | GATCCGGTGATTGATTGAG |
24 | pJV-empty-R | CTTACATTAATTGCGTTGCGC |
25 | VioD-F | AAAATTCTGGTGATTGGCGCGGGC |
26 | VioD-R | ttaCTCGAGGCGCTGCAGCGC |
27 | Bba-4VioD-F | cgagtaaGGATCCGAGGCTTGGATTCTCA |
28 | Bba-4vioD-R | ttttttacctccttaaggatcTTAGCGCTTGGCCGCGAAA |
29 | vioD-inschk-F | GCGGTTTTCGCGGCCAAGCG |
30 | vioD-inschk-R | GGCAGGGCGGGGCGTAATTTGAT |
Uppercase letters denote portion that anneals to original sequence.
The beta-carotene cluster was then inserted into the pJV298 plasmid [35] by Gibson assembly. Primers 3 and 4 were used to PCR amplify the beta-carotene cluster from plasmid TOPO-ßcar and primers 5 and 6 were used to PCR amplify pJV298. Reactions were digested with DpnI, and assembled with Gibson assembly. Assembly reactions were transformed into E. coli NEB10β, and DNA preparation afforded the plasmid pJV-beta-carotene. The insertion of the ß-carotene cluster was confirmed by colony PCR (using primers 1 and 2), patch plating confirming bacteria produced more orange pigment on plates containing IPTG, plasmid restriction digestion (HindIII), and sequencing. Plasmid pJV-ß-carotene was then electroporated into V. natriegens as described in Tschirhart et al. [10], resulting in strain V. natriegens pJV-ß-carotene. For a list of DNA features used for the different plasmids, see Table 4.
Table 4.
Name | Sequence |
---|---|
Ptac promoter | ttgacaattaatcatcggctcgtataatg |
J23102 promoter | ttgacagctagctcagtcctaggtactgtgctagc |
B0032m RBS | agagtcacacaggaaagtacta |
4.4. Cloning of the MVA Pathway
The two clusters (MVA1 = thil, hmdH, hmcS; MVA2 = mvaK, mvaD, pmvk, idi (Appendix B, Table A2) were PCR amplified separately from L. acidophilus NCFM genomic DNA [81] using primers 7 and 8, and 9 and 10, respectively. MVA1 underwent A-tailing, was inserted into the pCR™4-TOPO® TA vector similarly to above, and the reaction transformed into TOP10 E. coli. DNA preparation afforded the plasmid TOPO-MVA1. MVA2 was inserted into the pCR™4Blunt-TOPO® vector using the TOPO™ Blunt-End Cloning Kit™ for Sequencing (Thermo Fisher Scientific, Waltham, MA, USA) and the reaction transformed into TOP10 E. coli. DNA preparation afforded the plasmid TOPO-MVA2.
The MVA1 and MVA2 clusters were then inserted into the pJV-ß-carotene plasmid by Gibson assembly. First, primers 13 and 14 were used to PCR amplify the MVA2 cluster from plasmid TOPO-MVA2, and primers 15 and 16 were used to PCR amplify the J23102 constitutive promoter (from the Anderson promoter collection, http://parts.igem.org/Promoters/Catalog/Anderson) and B0032 RBS (the two together denoted as A5D5) from plasmid pA5D5GFP [10,82]. Primers 7 and 17 were used to PCR amplify pJV-ß-carotene. Assembly reactions were transformed into NEB10ß E. coli and produced the plasmid pJV-ß-carotene-A5D5-MVA2. The presence of MVA2 was confirmed by colony PCR (primers 13 and 14), plasmid restriction digestion mapping (NdeI), and by sequencing.
To incorporate MVA1 into pJV-ß-carotene-A5D5-MVA2 between A5D5 and MVA2, a second Gibson assembly was performed. Primers 18 and 19 were used for MVA1 from TOPO-MVA1 and primers 4 and 20 were used for the vector. Since it has been recorded that products from the MVA1 cluster can accumulate and be toxic to cells [68], the reaction was transformed into NEB10ß E. coli and IPTG was added to the SOC recovery media to activate the beta-carotene cluster to attempt to pull the reaction towards product (~1 mM final). Recovery proceeded for 40 min. Outgrowth was plated on LB plates with IPTG at 1 mM final concentration, and incubated overnight at 37 °C. Colonies were selected for growth with IPTG and DNA preparation resulted in plasmid pJV-ß-carotene-MVA. The plasmid was confirmed by colony PCR with primers 11 and 12 for MVA1 and 13 and 14 for MVA2, plasmid restriction digestion mapping (SpeI and BbsI, separately), and by sequencing. During sequencing, it was noted that a spontaneous mutation had occurred (G298T) in the crtY gene; however, HPLC analysis confirmed the strain still produced beta-carotene. Plasmid pJV-ß-carotene-MVA was then electroporated into V. natriegens, resulting in strain V. natriegens pJV-ß-carotene-MVA. For a list of DNA features used for the different plasmids, see Table 4.
4.5. Cloning of the Empty Control pJV298 Plasmid
To create an empty control vector variation of the pJV298 plasmid, we amplified the plasmid to exclude the region encompassing the lacIq repressor gene, promoter, and the Ptac promoter and gfp using the primers 23 and 24. The resultant PCR product was phosphorylated with NEB’s Polynucleotide Kinase (PNK) and then ligated using NEB’s T4 Ligase, according to manufacturer’s protocol. The resultant reaction was transformed into NEB10B cells according to manufacturer’s protocol. After overnight growth at 37 °C, colonies were analyzed for lack of green fluorescence upon IPTG induction (1 mM) overnight. For a list of DNA features used for the different plasmids, see Table 4.
4.6. Cloning of the Violacein Pathway
The plasmid containing most of the violacein pathway, BBa_J72214-BBa_J72090, was acquired from Addgene (BBa_J72214-BBa_J72090 was a gift from Christopher Anderson (Addgene plasmid # 40782; RRID:Addgene_40782; [43,83]). Information on the Addgene website indicated that sequencing confirmed the absence of the vioD gene [83]. Restriction enzyme digestion (SacI-HF) suggested, and partial sequencing by the authors of this manuscript confirmed, the absence of vioD. A synthesized vioD (ATUM, Newark, CA, USA http://www.atum.bio) based on the sequence from C. violaceum ATCC 12472 was recoded for E. coli (similarly to the rest of the genes [43,44,83]) and inserted into the BBa_J72214-BBa_J72090 plasmid using Gibson Assembly. The vioD gene was amplified using primers 25 and 26, and the vector with primers 27 and 28. NEB10β cells were transformed with the assembly as recommended. Colonies were tested by colony PCR with primers 29 and 30. DNA preparation afforded the plasmid pVio, with insertion of vioD confirmed with partial sequencing at each end of the gene. Plasmid pVio was then electroporated into V. natriegens, resulting in strain V. natriegens pVio. It is noted that the encoded VioB in the plasmid from Addgene was a variant as compared to the natural enzyme from C. violaceum (S303N), but the cluster was still able to produce violacein. For a list of DNA features used for the different plasmids, see Table 4.
4.7. Heterologous Production of Beta-carotene
For production of beta-carotene in LBv2 rich medium, overnight cultures of V. natriegens transformed with pJV298-C (empty control plasmid), pJV-ß-carotene, and pJV-ß-carotene-MVA were each inoculated into triplicate shaker flasks containing 25 mL of LBv2 media supplemented with chloramphenicol (6 µg/mL final). Cultures were incubated at 30 °C (250 rpm) in the dark for ~2–3 h until cultures reached approximate mid-log growth phase (OD600 ~ 0.7–0.8), were induced with IPTG (~1 mM final), and incubated overnight (~19.5–20.3 h). An aliquot of 1.8 mL was centrifuged at 8000 rpm (~4720 rcf) for 3 min, the pellet washed with 500 µL of PBS supplemented with 300 mM NaCl, and centrifuged at 8000 rpm for 6 min. The pellet was dissolved in acetone and incubated at 55 °C in the dark for 15 min similar to a published procedure for extracting beta-carotene [26]. The solution was centrifuged at 16,000 rcf for 10 min and an 800 µL aliquot of supernatant removed, dried under reduced pressure, and stored at –80 °C until analysis.
For production of beta-carotene in minimal media supplemented with different carbon sources (0.4%), starter cultures of V. natriegens transformed with pJV-ß-carotene-MVA were made in each of the different media (supplemented with chloramphenicol at 6 µg/mL) and grown overnight at 30 °C (250 rpm). Triplicate production cultures (5 mL) of each media were inoculated with starter cultures, incubated at 30 °C (250 rpm) in the dark until cultures reached approximate mid-log growth phase (OD600 ~> 0.6), and then induced with IPTG (~1 mM final). Since cultures in different media grew at different rates, induction was staggered (1.5 h max time difference). After 19 h of induction, cultures were moved to 4 °C. Beta-carotene extraction was then done as described for rich medium growth.
Beta-carotene production was determined by HPLC-UV. Samples were dissolved in acetone, followed by addition of 70:30 acetonitrile: methanol for a final 2:1 ratio. Samples were then centrifuged at 16,000 rcf for 10 min at 4 °C, and a portion of supernatant transferred for analysis. Randomized samples were analyzed on a Waters Acquity H-Class UPLC with a 2.1 x 50 mm BEH C18 1.7 µm column (Waters, Milford, MA, USA) and beta-carotene detected using an in-line PDA eλ detector at 453 nm (2.4 nm resolution; integrated area), with mass/charge confirmation of select samples using an in-line Waters SQ Detector 2 mass spectrometer in ESI positive mode. Samples were compared to a standard curve from a ß-carotene standard (Sigma Aldrich, St. Louis, MO, USA). The analysis was conducted similarly to Paliakov et al. [84]. Buffer A was 90:10 acetonitrile:H2O and buffer B was 70:30 methanol:isopropanol, and samples (2 µL injections) were analyzed using the following gradient at 40 °C at a flow-rate of 0.4 mL/min: 0 min, 60% B; 1.25 min, 60% B; 2 min, 60–80% B (linear); 4.5 min, 80% B; 5.25 min, 80–60% B (linear); 7.25 min, 60% B; beta-carotene eluted at ~2.75 min. Data are the average of triplicates, and error represents the standard deviation of the mean.
4.8. Heterologous Production of Violacein
For production of violacein in LBv2 rich medium and minimal media supplemented with different carbon sources, starter cultures of WT V. natriegens and V. natriegens transformed with pVio were made in LBv2 and grown overnight at 37 °C (250 rpm). Duplicate production cultures (5 mL) of each medium (triplicate for LBv2) were inoculated with starter cultures, incubated at 37 °C (250 rpm) for 44 h, similar to the time-scale used in a previous publication [20]. An aliquot of 500 µL was centrifuged at 8000 rpm (≈ 4,720 rcf) for 3 min. The pellet was extracted twice with 250 µL ethanol × and a portion of this (300 µL) dried under reduced vacuum and stored at −20 °C until analysis. After extraction of the pellet once more with ethanol, the pellet was dissolved in PBS and an OD600nm measurement taken to estimate cell density, similar to a published method [20].
Violacein production was determined by HPLC-UV. Samples were dissolved in ethanol, centrifuged at 16,000 rcf for 10 min at 4 °C, and 40 µL of supernatant transferred for analysis. Randomized samples were analyzed on the same instrumentation as for beta-carotene (see above) but the PDA detector was set at 575 nm and 560 nm for violacein and deoxyviolacein, respectively (both at 2.4 nm resolution). Samples were compared to a standard curve from a violacein standard (>98%, violacein from Janthinobacterium lividum, Sigma Aldrich, St. Louis, MO, USA) and a deoxyviolacein standard (deoxyviolacein, Cayman Chemical, Ann Arbor, MI, USA). Note that deoxyviolacein is contained within the violacein standard from Sigma Aldrich but appeared to be a minor constituent and so was not considered during standard curve calculation (sold as minimum 85% violacein). Buffer A was 0.1% formic acid in H2O and buffer B was 0.1% formic acid in acetonitrile, and samples (2 µL injections) were analyzed using the following gradient at 45 °C at a flow-rate of 0.4 mL/min: 0 min, 2% B; 2 min, 2% B; 7.5 min, 2–95% B (linear); 10 min, 95% B; 10.5 min, 95–2% B (instant); 12.5 min, 2% B; violacein eluted at ~4.64 min and deoxyviolacein eluted at ~5.04 min. Data are the average of duplicates (triplicate for LBv2 medium), and error for LBv2 medium represents the standard derivation of the mean.
4.9. Statistical Significance Analysis
For determination of statistical significance of beta-carotene production between V. natriegens expressing pJV-ß-carotene and pJV-ß-carotene-MVA in LBv2 medium, a two-sample assuming unequal variances t-test was done using Excel 2013 Data Analysis (Microsoft, Redmond, WA, USA). For determination of statistical significance of beta-carotene production or growth in minimal media supplemented with different carbon sources, first a single factor ANOVA was done using Excel 2013 Data Analysis (Microsoft, Redmond, WA, USA) to determine if the p-value was less than 0.05 and if F was greater than F crit. If so, a Tukey-Kramer analysis was done on each paired interaction, as calculated by: (1) determining the absolute difference, d, between averages calculated by ANOVA; (2) denoting the number of replicates, n, for each condition; (3) determining the standard error, SE, using the equation: SE = square root(0.5 × MSw × (1/n1 + 1/n2)), where MSw = the mean square error within groups calculated by ANOVA, and n1 and n2 are the biological replicates for each condition; and (4) determining the q statistic, q, as the absolute value of d/SE (Dr. Todd Grande, https://www.youtube.com/watch?v=_I4O3xxh2ns). Finally, q was compared to a table of q values (https://www2.stat.duke.edu/courses/Spring98/sta110c/qtable.html); if q was greater than the q value from the table for α = 0.05, df (as determined by ANOVA for within groups), and the number of conditions, the null hypothesis was rejected and the data was considered statistically different.
Acknowledgments
The opinions and assertions contained herein are those of the authors and are not to be construed as those of the U.S. Navy, military service at large or U.S. Government. Author T.T. holds an American Society for Engineering Education (ASEE) Research Fellowship award and author J.S. holds a National Research Council (NRC) Research Associateship award, both at NRL. The authors would like to thank Meghna Thakur for her help with the vioD gene.
Appendix A: Additional BioLog Results
Table A1.
Compound | Response | Compound | Response |
---|---|---|---|
Carbohydrates | Carboxylic acids, cont. | ||
D-Glucosamine | 159 | Monomethyl succinate | 82 |
D-Ribose | 154 | Butyric acid | 81 |
Inosine | 145 | α-Ketobutyric acid | 80 |
L-Arabinose | 145 | 4-Hydroxybenzoic acid | 73 |
Uridine | 133 | 5-Keto-D-gluconic acid | 70 |
2′-Deoxyadenosine | 131 | Formic acid | 69 |
D-Fructose | 131 | Oxalomalic acid | 54 |
Adenosine | 128 | D-Malic acid | 50 |
D-Galactose | 123 | Amino acids | |
Glycerol | 122 | Gly-Asp | 149 |
ß-Methyl-D-glucoside | 116 | L-Glutamic acid | 149 |
Thymidine | 116 | L-Asparagine | 148 |
L-Rhamnose | 106 | L-Aspartic acid | 148 |
D-Mannitol | 105 | D-Alanine | 147 |
Arbutin | 100 | L-Glutamine | 140 |
D-Cellobiose | 95 | Ala-Gly | 137 |
Maltose | 92 | L-Proline | 136 |
Maltotrioise | 88 | L-Serine | 136 |
Sucrose | 88 | L-Threonine | 129 |
α-D-Glucose | 87 | L-Alanine | 128 |
D-Trehalose | 82 | Gly-Pro | 117 |
N-Acetyl-D-Glucosamine | 79 | Hydroxy-L-proline | 113 |
D-Arabinose | 78 | L-Histidine | 108 |
Gentiobiose | 73 | L-Arginine | 98 |
L-Lyxose | 70 | Glycine | 96 |
D,L-α-Glycerol phosphate | 65 | Gly-Glu | 94 |
D-Arabitol | 56 | L-Ornithine | 80 |
Carboxylic acids | L-Pyroglutamic acid | 79 | |
L-Malic acid | 145 | D-Serine | 52 |
Succinic acid | 135 | Polymers | |
Fumaric acid | 134 | Dextrin | 112 |
Pyruvic acid | 132 | Pectin | 110 |
D-Gluconic acid | 129 | Laminarin | 95 |
L-Lactic acid | 128 | Gamma-cyclodextrin | 62 |
Acetic acid | 119 | Fatty acids | |
D,L-Malic acid | 119 | Tween 20 | 109 |
Citric acid | 116 | Tween 40 | 108 |
Bromosuccinic acid | 104 | Tween 80 | 92 |
Propionic acid | 102 | Esters | |
Malonic acid | 97 | Methylpyruvate | 107 |
Quinic acid | 97 | Amines | |
γ-amino-N-butyric acid | 92 | Putrescine | 67 |
ß-hydroxybutyric acid | 90 | Alcohols | |
α-Hydroxybutric acid | 87 | Dihydroxyacetone | 58 |
Appendix B: Additional Information Regarding Genes used in this Study
Table A2.
Protein | Gene | Gene ID | #bp 3 | Notes 4 | Source/Ref 5 |
---|---|---|---|---|---|
Lycopene cyclase | crtY 1 | 5556089 | 1158 | crtB(14) | Vc |
Phytoene/squalene synthase family protein | crtB 1 | 5556092 | 915 | crtY(14), crtI(20) | Vc |
Phytoene desaturase | crtI 1 | 5556083 | 1614 | crtB(20), crtE(11) | Vc |
Polyprenyl synthetase | crtE 1 | 5556114 | 864 | crtI(11) | Vc |
Acetyl-CoA acetyltransferase | thil | 3252766 | 1158(1169) | hmdH(1) | La |
Hydroxymethyl glutaryl-CoA reductase | hmdH | 3252708 | 1212 | thil(1) | La |
Hydroxymethyl glutaryl-CoA synthase | hmcS | 3252698 | 1164 | La | |
Mevalonate kinase | mvaK | 3253078 | 909(923) | La | |
Mevalonate diphosphate decarboxylate | mvaD | 3253057 | 963 | La | |
Phosphomevalonate kinase | pmvk 2 | 3253097 | 1083(1097) | La | |
Isopentenyl pyrophosphate isomerase | idi 2 | 3253102 | 1020(1034) | La | |
L-tryptophan synthase | vioA | 24947400 | 1257 | Cv | |
Iminophenyl-pyruvate dimer synthase | vioB | 24945600 | 2997 | Cv | |
Protodeoxyviolaceinate monooxygenase | vioE | 24949508 | 576 | Cv | |
Tryptophan hydroxylase | vioD | 24947515 | 1122 | Cv | |
Violacein synthase | vioC | 24948167 | 1290 | Cv |
1 Common name (homologous); 2 Common name (homologous) by searching protein name in UniProtKB; 3 base pairs (parenthesis include ribosome binding site sequence); 4 Overlaps with given gene (parenthesis indicate number of bp overlapping); 5 Gene source: Vc = V. campbellii BAA-1116 NCBI accession number NC_009783.1; La = L. acidophilus NCFM NCBI accession number NC_006814.3; Cv = C. violaceum ATCC 12472 NCBI accession number NC_005085.1.
Appendix C: Plasmid Maps
Author Contributions
Author contributions were as follows: conceptualization, G.A.E. and T.T.; methodology, G.A.E., T.T., J.S., S.A.W., I.L.M., and G.J.V.; software, -; validation, G.A.E. and T.T.; formal analysis, G.A.E. and T.T.; investigation, G.A.E. and T.T.; resources, S.A.W., I.L.M., and G.J.V.; data curation, G.A.E. and T.T.; writing—original draft preparation, G.A.E. and T.T.; writing—review and editing, G.A.E., T.T., J.S., S.A.W., I.L.M., and G.J.V.; visualization, G.A.E. and T.T.; supervision, S.A.W., I.L.M., and G.J.V.; project administration, G.A.E., T.T., and G.J.V; funding acquisition, S.A.W., I.L.M., and G.J.V.
Funding
This work was supported by the Assistant Secretary of Defense for Research and Engineering (ASD(R&E)) through the Applied Research for Advancement of S&T Priorities Synthetic Biology for Military Environments program, the NRL Nanoscience Institute, and the National Institute of Food and Agriculture, U.S. Department of Agriculture, under Award 11901762.
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
References
- 1.Adams B.L. The next generation of synthetic biology chassis: Moving synthetic biology from the laboratory to the field. ACS Synth. Biol. 2016;5:1328–1330. doi: 10.1021/acssynbio.6b00256. [DOI] [PubMed] [Google Scholar]
- 2.Calero P., Nikel P.I. Chasing bacterial chassis for metabolic engineering: A perspective review from classical to non-traditional microorganisms. Microb. Biotechnol. 2019;12:98–124. doi: 10.1111/1751-7915.13292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Russell J.J., Theriot J.A., Sood P., Marshall W.F., Landweber L.F., Fritz-Laylin L., Polka J.K., Oliferenko S., Gerbich T., Gladfelter A., et al. Non-model model organisms. BMC Biol. 2017;15:55. doi: 10.1186/s12915-017-0391-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Payne W.J., Eagon R.G., Williams A.K. Some observations on the physiology of Pseudomonas natriegens nov. spec. Antonie Van Leeuwenhoek. 1961;27:121–128. doi: 10.1007/BF02538432. [DOI] [PubMed] [Google Scholar]
- 5.Dalia T.N., Hayes C.A., Stolyar S., Marx C.J., McKinlay J.B., Dalia A.B. Multiplex genome editing by natural transformation (MuGENT) for synthetic biology in Vibrio natriegens. ACS Synth. Biol. 2017;6:1650–1655. doi: 10.1021/acssynbio.7b00116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Eagon R.G. Pseudomonas natriegens, a marine bacterium with a generation time of less than 10 minutes. J. Bacteriol. 1962;83:736–737. doi: 10.1128/jb.83.4.736-737.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hoffart E., Grenz S., Lange J., Nitschel R., Muller F., Schwentner A., Feith A., Lenfers-Lucker M., Takors R., Blombach B. High substrate uptake rates empower Vibrio natriegens as production host for industrial biotechnology. Appl. Environ. Microbiol. 2017;83:e01614-17. doi: 10.1128/AEM.01614-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lee H.H., Ostrov N., Wong B.G., Gold M.A., Khalil A.S., Church G.M. Functional genomics of the rapidly replicating bacterium Vibrio natriegens by CRISPRi. Nat. Microbiol. 2019;4:1105–1113. doi: 10.1038/s41564-019-0423-8. [DOI] [PubMed] [Google Scholar]
- 9.Long C.P., Gonzalez J.E., Cipolla R.M., Antoniewicz M.R. Metabolism of the fast-growing bacterium Vibrio natriegens elucidated by (13)C metabolic flux analysis. Metab. Eng. 2017;44:191–197. doi: 10.1016/j.ymben.2017.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tschirhart T., Shukla V., Kelly E.E., Schultzhaus Z., NewRingeisen E., Erickson J.S., Wang Z., Garcia W., Curl E., Egbert R.G., et al. Synthetic biology parts and tools for the fast-growing marine bacterium Vibrio natriegens. ACS Synth. Biol. 2019;8:2069–2079. doi: 10.1021/acssynbio.9b00176. [DOI] [PubMed] [Google Scholar]
- 11.Wang Z., Lin B., Hervey W.J.t., Vora G.J. Draft genome sequence of the fast-growing marine bacterium Vibrio natriegens strain ATCC 14048. Genome Announc. 2013;1:e00589-13. doi: 10.1128/genomeA.00589-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Weinstock M.T., Hesek E.D., Wilson C.M., Gibson D.G. Vibrio natriegens as a fast-growing host for molecular biology. Nat. Methods. 2016;13:849–851. doi: 10.1038/nmeth.3970. [DOI] [PubMed] [Google Scholar]
- 13.Lim H.G., Kwak D.H., Park S., Woo S., Yang J.S., Kang C.W., Kim B., Noh M.H., Seo S.W., Jung G.Y. Vibrio sp. dhg as a platform for the biorefinery of brown macroalgae. Nat. Commun. 2019;10:2486. doi: 10.1038/s41467-019-10371-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Roberts A.D., Finnigan W., Wolde-Michael E., Kelly P., Blaker J.J., Hay S., Breitling R., Takano E., Scrutton N.S. Synthetic biology for fibers, adhesives, and active camouflage materials in protection and aerospace. MRS Commun. 2019;9:486–504. doi: 10.1557/mrc.2019.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tao W., Lv L., Chen G.Q. Engineering Halomonas species TD01 for enhanced polyhydroxyalkanoates synthesis via CRISPRi. Microb. Cell Fact. 2017;16:48. doi: 10.1186/s12934-017-0655-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wendisch V.F., Brito L.F., Gil Lopez M., Hennig G., Pfeifenschneider J., Sgobba E., Veldmann K.H. The flexible feedstock concept in industrial biotechnology: Metabolic engineering of Escherichia coli, Corynebacterium glutamicum, Pseudomonas, Bacillus and yeast strains for access to alternative carbon sources. J. Biotechnol. 2016;234:139–157. doi: 10.1016/j.jbiotec.2016.07.022. [DOI] [PubMed] [Google Scholar]
- 17.Harrison R.G., Todd P.W., Rudge S.R., Petrides D.P. Bioseparations Science and Engineering. 2nd ed. Oxford University Press; Oxford, UK: 2015. p. 432. [Google Scholar]
- 18.Sabri S., Nielsen L.K., Vickers C.E. Molecular control of sucrose utilization in Escherichia coli W, an efficient sucrose-utilizing strain. Appl. Environ. Microbiol. 2013;79:478–487. doi: 10.1128/AEM.02544-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Choi S.Y., Yoon K.H., Lee J.I., Mitchell R.J. Violacein: Properties and production of a versatile bacterial pigment. Biomed. Res. Int. 2015;2015:465056. doi: 10.1155/2015/465056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fang M.Y., Zhang C., Yang S., Cui J.Y., Jiang P.X., Lou K., Wachi M., Xing X.H. High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway. Microb. Cell Fact. 2015;14:8. doi: 10.1186/s12934-015-0192-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Jeschek M., Gerngross D., Panke S. Rationally reduced libraries for combinatorial pathway optimization minimizing experimental effort. Nat. Commun. 2016;7:11163. doi: 10.1038/ncomms11163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jiang P.X., Wang H.S., Zhang C., Lou K., Xing X.H. Reconstruction of the violacein biosynthetic pathway from Duganella sp. B2 in different heterologous hosts. Appl. Microbiol. Biotechnol. 2010;86:1077–1088. doi: 10.1007/s00253-009-2375-z. [DOI] [PubMed] [Google Scholar]
- 23.Jones J.A., Vernacchio V.R., Lachance D.M., Lebovich M., Fu L., Shirke A.N., Schultz V.L., Cress B., Linhardt R.J., Koffas M.A. ePathOptimize: A combinatorial approach for transcriptional balancing of metabolic pathways. Sci. Rep. 2015;5:11301. doi: 10.1038/srep11301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kim J.H., Kim S.-W., Nguyen D.Q.A., Li H., Kim S.B., Seo Y.-G., Yang J.-K., Chung I.-Y., Kim D.H., Kim C.-J. Production of β-carotene by recombinant Escherichia coli with engineered whole mevalonate pathway in batch and fed-batch cultures. Biotechnol. Bio process Eng. 2009;14:559–564. doi: 10.1007/s12257-008-0230-1. [DOI] [Google Scholar]
- 25.Moore S.J., Lai H.E., Kelwick R.J., Chee S.M., Bell D.J., Polizzi K.M., Freemont P.S. EcoFlex: A multifunctional MoClo kit for E. coli synthetic biology. ACS Synth. Biol. 2016;5:1059–1069. doi: 10.1021/acssynbio.6b00031. [DOI] [PubMed] [Google Scholar]
- 26.Yang J., Guo L. Biosynthesis of β-carotene in engineered E. coli using the MEP and MVA pathways. Microb. Cell Fact. 2014;13:160–170. doi: 10.1186/s12934-014-0160-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ye L., Zhang C., Bi C., Li Q., Zhang X. Combinatory optimization of chromosomal integrated mevalonate pathway for beta-carotene production in Escherichia coli. Microb. Cell Fact. 2016;15:202. doi: 10.1186/s12934-016-0607-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yoon S.H., Lee S.H., Das A., Ryu H.K., Jang H.J., Kim J.Y., Oh D.K., Keasling J.D., Kim S.W. Combinatorial expression of bacterial whole mevalonate pathway for the production of β-carotene in E. coli. J. Biotechnol. 2009;140:218–226. doi: 10.1016/j.jbiotec.2009.01.008. [DOI] [PubMed] [Google Scholar]
- 29.Yoon S.-H.Y., Park H.-M., Kim J.-E.K., Lee S.-H., Choi M.-S., Kim J.-Y.K., Oh D.-K.O., Keasling J.D., Kim S.-W. Increased ß-carotene production in recombinant Escherichia coli harboring an engineered isoprenoid precursor pathway with mevalonate addition. Biotechnol. Prog. 2007;23:599–605. doi: 10.1021/bp070012p. [DOI] [PubMed] [Google Scholar]
- 30.Flesch G., Rohmer M. Prokaryotic hopanoids: The biosynthesis of the bacteriohopane skeleton. Eur. J. Biochem. 1988;175:405–411. doi: 10.1111/j.1432-1033.1988.tb14210.x. [DOI] [PubMed] [Google Scholar]
- 31.Rodríguez-Concepción M., Boronat A. Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiol. 2002;130:1079–1089. doi: 10.1104/pp.007138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wang Z., Lin B., Mostaghim A., Rubin R.A., Glaser E.R., Mittraparp-Arthorn P., Thompson J.R., Vuddhakul V., Vora G.J. Vibrio campbellii hmgA-mediated pyomelanization impairs quorum sensing, virulence, and cellular fitness. Front. Microbiol. 2013;4:379. doi: 10.3389/fmicb.2013.00379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wang Z., O’Shaughnessy T.J., Soto C.M., Rahbar A.M., Robertson K.L., Lebedev N., Vora G.J. Function and regulation of Vibrio campbellii proteorhodopsin: Acquired phototrophy in a classical organoheterotroph. PLoS ONE. 2012;7:e38749. doi: 10.1371/journal.pone.0038749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dunn A.K., Millikan D.S., Adin D.M., Bose J.L., Stabb E.V. New rfp- and pES213-derived tools for analyzing symbiotic Vibrio fischeri reveal patterns of infection and lux expression in situ. Appl. Environ. Microbiol. 2006;72:802–810. doi: 10.1128/AEM.72.1.802-810.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.van Kessel J.C., Rutherford S.T., Cong J.P., Quinodoz S., Healy J., Bassler B.L. Quorum sensing regulates the osmotic stress response in Vibrio harveyi. J. Bacteriol. 2015;197:73–80. doi: 10.1128/JB.02246-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Altermann E., Russell W.M., Azcarate-Peril M.A., Barrangou R., Buck B.L., McAuliffe O., Souther N., Dobson A., Duong T., Callanan M., et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc. Natl. Acad. Sci. USA. 2005;102:3906–3912. doi: 10.1073/pnas.0409188102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Balibar C.J., Walsh C.T. In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA-E from Chromobacterium violaceum. Biochemistry. 2006;45:15444–15457. doi: 10.1021/bi061998z. [DOI] [PubMed] [Google Scholar]
- 38.Dantas C., Volpe P.L.O., Durán N., Ferreira M.M.C. The violacein biosynthesis monitored by multi-wavelength fluorescence spectroscopy and by the PARAFAC method. J. Braz. Chem. Soc. 2012;23:2054–2064. doi: 10.1590/S0103-50532012005000083. [DOI] [Google Scholar]
- 39.iGEM. [(accessed on 23 July 2019)]; Available online: https://2016.igem.org/Team:Washington/Project1.
- 40.Kim S., Thiessen P.A., Bolton E.E., Chen J., Fu G., Gindulyte A., Han L., He J., He S., Shoemaker B.A., et al. PubChem Substance and Compound databases. Nucleic Acids Res. 2016;44:D1202–D1213. doi: 10.1093/nar/gkv951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lee M.E., Aswani A., Han A.S., Tomlin C.J., Dueber J.E. Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Res. 2013;41:10668–10678. doi: 10.1093/nar/gkt809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Brazilian National Genome Project C. The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc. Natl. Acad. Sci. USA. 2003;100:11660–11665. doi: 10.1073/pnas.1832124100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kittleson J.T., DeLoache W., Cheng H.Y., Anderson J.C. Scalable plasmid transfer using engineered P1-based phagemids. ACS Synth. Biol. 2012;1:583–589. doi: 10.1021/sb300054p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sarovich D.S., Pemberton J.M. pPSX: A novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters. Plasmid. 2007;57:306–313. doi: 10.1016/j.plasmid.2006.11.004. [DOI] [PubMed] [Google Scholar]
- 45.Pfeifer E., Michniewski S., Gätgens C., Münch E., Müller F., Polen T., Millard A., Blombach B., Frunzke J. Generation of a prophage-free variant of the fast-growing bacterium Vibrio natriegens. Appl. Environ. Microbiol. 2019;85:e00853-19. doi: 10.1128/AEM.00853-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Failmezger J., Scholz S., Blombach B., Siemann-Herzberg M. Cell-free protein synthesis from fast-growing Vibrio natriegens. Front. Microbiol. 2018;9:1146. doi: 10.3389/fmicb.2018.01146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Darlington A.P.S., Kim J., Jimenez J.I., Bates D.G. Dynamic allocation of orthogonal ribosomes facilitates uncoupling of co-expressed genes. Nat. Commun. 2018;9:695. doi: 10.1038/s41467-018-02898-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Gyorgy A., Jimenez J.I., Yazbek J., Huang H.H., Chung H., Weiss R., Del Vecchio D. Isocost Lines Describe the Cellular Economy of Genetic Circuits. Biophys. J. 2015;109:639–646. doi: 10.1016/j.bpj.2015.06.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Aiyar S.E., Gaal T., Gourse R.L. rRNA promoter activity in the fast-growing bacterium Vibrio natriegens. J. Bacteriol. 2002;184:1349–1358. doi: 10.1128/JB.184.5.1349-1358.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.European Commission. [(accessed on 23 July 2019)]; Available online: https://cordis.europa.eu/project/rcn/199219/factsheet/en.
- 51.Metgen. [(accessed on 23 July 2019)]; Available online: http://www.metgen.com/retapp/
- 52.Steinbach D., Kruse A., Sauer J., Vetter P. Sucrose is a promising feedstock for the synthesis of the platform chemical hydroxymethylfurfural. Energies. 2018;11:645. doi: 10.3390/en11030645. [DOI] [Google Scholar]
- 53.Enquist-Newman M., Faust A.M., Bravo D.D., Santos C.N., Raisner R.M., Hanel A., Sarvabhowman P., Le C., Regitsky D.D., Cooper S.R., et al. Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform. Nature. 2014;505:239–243. doi: 10.1038/nature12771. [DOI] [PubMed] [Google Scholar]
- 54.Lee H.H., Ostrov N., Wong B.G., Gold M.A., Khalil A., Church G.M. Vibrio natriegens, a new genomic powerhouse. bioRxiv. 2016:058487. [Google Scholar]
- 55.International Energy Agency (IEA) Biofuels for Transport: An International Perspective. IEA; Paris, France: 2004. [Google Scholar]
- 56.Bruschi M., Boyes S.J., Sugiarto H., Nielsen L.K., Vickers C.E. A transferable sucrose utilization approach for non-sucrose-utilizing Escherichia coli strains. Biotechnol. Adv. 2012;30:1001–1010. doi: 10.1016/j.biotechadv.2011.08.019. [DOI] [PubMed] [Google Scholar]
- 57.Arifin Y., Sabri S., Sugiarto H., Kromer J.O., Vickers C.E., Nielsen L.K. Deletion of cscR in Escherichia coli W improves growth and poly-3-hydroxybutyrate (PHB) production from sucrose in fed batch culture. J. Biotechnol. 2011;156:275–278. doi: 10.1016/j.jbiotec.2011.07.003. [DOI] [PubMed] [Google Scholar]
- 58.Koutinas A.A., Wang R., Webb C. Evaluation of wheat as generic feedstock for chemical production. Ind. Crop. Prod. 2004;20:75–88. doi: 10.1016/j.indcrop.2003.12.013. [DOI] [Google Scholar]
- 59.Jahrels K., Lengeler J.W. Molecular analysis of two ScrR repressors and of a ScrR–FruR hybrid repressor for sucrose and D-fructose specific regulons from enteric bacteria. Mol. Microbiol. 1993;9:195–209. doi: 10.1111/j.1365-2958.1993.tb01681.x. [DOI] [PubMed] [Google Scholar]
- 60.Zhao J., Li Q., Sun T., Zhu X., Xu H., Tang J., Zhang X., Ma Y. Engineering central metabolic modules of Escherichia coli for improving beta-carotene production. Metab. Eng. 2013;17:42–50. doi: 10.1016/j.ymben.2013.02.002. [DOI] [PubMed] [Google Scholar]
- 61.Bogacz-Radomska L., Harasym J. β-Carotene—Properties and production methods. Food Qual. Saf. 2018;2:69–74. doi: 10.1093/fqsafe/fyy004. [DOI] [Google Scholar]
- 62.Alonso-Gutierrez J., Chan R., Batth T.S., Adams P.D., Keasling J.D., Petzold C.J., Lee T.S. Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production. Metab. Eng. 2013;19:33–41. doi: 10.1016/j.ymben.2013.05.004. [DOI] [PubMed] [Google Scholar]
- 63.Lemuth K., Steuer K., Albermann C. Engineering of a plasmid-free Escherichia coli strain for improved in vivo biosynthesis of astaxanthin. Microb. Cell Fact. 2011;10:29–40. doi: 10.1186/1475-2859-10-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wang C.-W., Oh M.-K., Liao J.C. Engineered isoprenoid pathway enhances astaxanthin production in Escherichia coli. Biotechnol. Bioeng. 1999;62:235–241. doi: 10.1002/(SICI)1097-0290(19990120)62:2<235::AID-BIT14>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- 65.Willrodt C., David C., Cornelissen S., Bühler B., Julsing M.K., Schmid A. Engineering the productivity of recombinant Escherichia coli for limonene formation from glycerol in minimal media. Biotechnol. J. 2014;9:1000–1012. doi: 10.1002/biot.201400023. [DOI] [PubMed] [Google Scholar]
- 66.Yang J., Zhao G., Sun Y., Zheng Y., Jiang X., Liu W., Xian M. Bio-isoprene production using exogenous MVA pathway and isoprene synthase in Escherichia coli. Bioresour. Technol. 2012;104:642–647. doi: 10.1016/j.biortech.2011.10.042. [DOI] [PubMed] [Google Scholar]
- 67.Yang J., Xian M., Su S., Zhao G., Nie Q., Jiang X., Zheng Y., Liu W. Enhancing production of bio-isoprene using hybrid MVA pathway and isoprene synthase in E. coli. PLoS ONE. 2012;7:e33509. doi: 10.1371/journal.pone.0033509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Pitera D.J., Paddon C.J., Newman J.D., Keasling J.D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 2007;9:193–207. doi: 10.1016/j.ymben.2006.11.002. [DOI] [PubMed] [Google Scholar]
- 69.Liu W., Luo Z., Wang Y., Pham N.T., Tuck L., Perez-Pi I., Liu L., Shen Y., French C., Auer M., et al. Rapid pathway prototyping and engineering using in vitro and in vivo synthetic genome SCRaMbLE-in methods. Nat. Commun. 2018;9:1936. doi: 10.1038/s41467-018-04254-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Yang C., Jiang P., Xiao S., Zhang C., Lou K., Xing X.-H. Fed-batch fermentation of recombinant Citrobacter freundii with expression of a violacein-synthesizing gene cluster for efficient violacein production from glycerol. Biochem. Eng. J. 2011;57:55–62. doi: 10.1016/j.bej.2011.08.008. [DOI] [Google Scholar]
- 71.Liu Y., Zhang Y.G., Zhang R.B., Zhang F., Zhu J. Glycerol/glucose co-fermentation: One more proficient process to produce propionic acid by Propionibacterium acidipropionici. Curr. Microbiol. 2011;62:152–158. doi: 10.1007/s00284-010-9683-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.VanBriesen J.M. Evaluation of methods to predict bacterial yield using thermodynamics. Biodegradation. 2002;13:171–190. doi: 10.1023/A:1020887214879. [DOI] [PubMed] [Google Scholar]
- 73.Fernández-Llamosas H., Castro L., Blázquez M.L., Díaz E., Carmona M. Speeding up bioproduction of selenium nanoparticles by using Vibrio natriegens as microbial factory. Sci. Rep. 2017;7:16046. doi: 10.1038/s41598-017-16252-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Benson D.A., Cavanaugh M., Clark K., Karsch-Mizrachi I., Lipman D.J., Ostell J., Sayers E.W. GenBank. Nucleic Acids Res. 2017;45:D37–D42. doi: 10.1093/nar/gkw1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Brister J.R., Ako-Adjei D., Bao Y., Blinkova O. NCBI viral genomes resource. Nucleic Acids Res. 2015;43:D571–D577. doi: 10.1093/nar/gku1207. (Database issue) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.O’Leary N.A., Wright M.W., Brister J.R., Ciufo S., Haddad D., McVeigh R., Rajput B., Robbertse B., Smith-White B., Ako-Adjei D., et al. Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44:D733–D745. doi: 10.1093/nar/gkv1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Tatusova T., DiCuccio M., Badretdin A., Chetvernin V., Nawrocki E.P., Zaslavsky L., Lomsadze A., Pruitt K.D., Borodovsky M., Ostell J. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016;44:6614–6624. doi: 10.1093/nar/gkw569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Kanehisa M., Sato Y., Furumichi M., Morishima K., Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590–D595. doi: 10.1093/nar/gky962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Bochner B.R., Gadzinski P., Panomitros E. Phenotype MicroArrays for high-throughput phenotypic testing and assay of gene function. Genome Res. 2001;11:1246–1255. doi: 10.1101/gr.186501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Zhou L., Lei X.H., Bochner B.R., Wanner B.L. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J. Bacteriol. 2003;185:4956–4972. doi: 10.1128/JB.185.16.4956-4972.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Spangler J.R., Caruana J.C., Phillips D.A., Walper S.A. Broad range shuttle vector construction and promoter evaluation for the use of Lactobacillus plantarum WCFS1 as a microbial engineering platform. Synth. Biol. 2019;4:ysz012. doi: 10.1093/synbio/ysz012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Iverson S.V., Haddock T.L., Beal J., Densmore D.M. CIDAR MoClo: Improved MoClo assembly standard and new E. coli part library enable rapid combinatorial design for synthetic and traditional biology. ACS Synth. Biol. 2016;5:99–103. doi: 10.1021/acssynbio.5b00124. [DOI] [PubMed] [Google Scholar]
- 83.Addgene. [(accessed on 9 July 2019)]; Available online: https://www.addgene.org/40782/
- 84.Paliakov E.M., Crow B.S., Bishop M.J., Norton D., George J., Bralley J.A. Rapid quantitative determination of fat-soluble vitamins and coenzyme Q-10 in human serum by reversed phase ultra-high pressure liquid chromatography with UV detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009;877:89–94. doi: 10.1016/j.jchromb.2008.11.012. [DOI] [PubMed] [Google Scholar]